首页> 外文OA文献 >Developmental changes in rat brain 5'-deiodinase and thyroid hormones during the fetal period: The effects of fetal hypothyroidism and maternal thyroid hormones
【2h】

Developmental changes in rat brain 5'-deiodinase and thyroid hormones during the fetal period: The effects of fetal hypothyroidism and maternal thyroid hormones

机译:胎儿期大鼠脑5'-脱碘酶和甲状腺激素的发育变化:胎儿甲状腺功能减退和母体甲状腺激素的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have studied the ontogenesis of 5'-deiodinase (5'D) activity in rat brain during fetal life, its capacity to respond to maternal or fetal hypothyroidism, and its regulation by maternal thyroid hormones. Type II 5'D (5' D-II) activity increases 4-fold during the period studied (17 to 22 days of gestation), mainly between days 19 and 21. Fetal brain T4 concentrations increase in parallel with fetal plasma T4, whereas fetal brain T3 concentrations increase 18 times (days 17-21), six times more than would have been expected from the small increase in fetal plasma T3 levels. Maternal thyroidectomy did not affect 5'D-II activity or thyroid hormone concentrations in fetal brain (expect brain T4 at 18 days of gestation). Fetal hypothyroidism, induced by giving a goitrogen (methimazole) to the mothers, depleted all fetal tissues studied, including the fetal thyroid, from thyroid hormones. By 19 days of gestation, the fetal brain was able to respond to hypothyroidism with a 3- to 5-fold increase in 5'D-II activity. Earlier onset of treatment with methimazole led to 2- to 3-fold increases in 5'D already at 17 and 18 days of gestation, showing the when fetal thyroid secretion starts the fetal brain 5'D-II is able to respond to hypothyroidism. Replacement of methimazole-treated mothers with physiological doses of T4, given by constant infusion, increased T4 and T3 concentrations in fetal brain, and inhibited fetal, as well as maternal, brain 5'D-II activity. But treatment of the mothers with T3 did not change T3 concentrations in the fetal brain, despite the increase in fetal plasma T3, and actually increased 5'D-II in fetal brain. Maternal cerebral 5'D-II was not inhibited by T3 treatment. Inverse relationships were found between the 5'D-II and thyroid hormone concentrations in the fetal brain. These correlations were not identical for fetuses from thyroidectomized and control mothers. In fetuses from thyroidectomized dams, brain 5'D-II is more sensitive to a decrease in brain T4 than in the progeny of control dams. The present results describe the developmental changes in rat cerebral 5'D-II activity and its regulation by thyroid hormones. Although fetal plasma T3 is 10% of adult levels, T3 concentrations in fetal brain increase almost to adult levels, suggesting an important role of local T3 production from T4, and thus, of 5'D-II in fetal brain. In addition, brain 5'D-II responds to thyroid hormone deficiency and can be modualted by maternal thyroid hormones when the fetus is hypothyroid.
机译:我们已经研究了胎儿生命期间大鼠脑中5'-脱碘酶(5'D)的活性,其对母体或胎儿甲状腺功能低下的反应能力以及母体甲状腺激素的调节作用。 II型5'D(5'D-II)活性在研究期间(妊娠17至22天)增加了4倍,主要是在第19天到21天之间。胎儿脑T4浓度与胎儿血浆T4平行增加,而胎儿脑中T3浓度增加了18倍(第17-21天),比胎儿血浆T3水平的小幅增加所预期的要多六倍。孕妇甲状腺切除术不会影响胎儿脑中5'D-II活性或甲状腺激素浓度(预计在妊娠18天时脑T4)。给予母亲甲状腺激素(methimazole)引起的胎儿甲状腺功能减退症,从甲状腺激素中耗尽了所有研究的胎儿组织,包括胎儿甲状腺。到妊娠19天时,胎脑能够对甲状腺功能减退症做出反应,使5'D-II活性增加3至5倍。甲巯咪唑治疗的较早发作已导致在妊娠17和18天时5'D升高了2到3倍,这表明胎儿甲状腺分泌开始时胎脑5'D-II能够对甲状腺功能减退做出反应。通过持续输注给予生理剂量的T4代替甲巴唑治疗的母亲,可增加胎儿脑中T4和T3的浓度,并抑制胎儿以及母体脑5'D-II的活性。但是,尽管胎儿血浆T3升高,但用T3治疗母亲并没有改变胎儿脑中T3的浓度,实际上却增加了胎儿脑中5'D-II的含量。孕妇脑5'D-II不受T3治疗的抑制。胎儿脑中5'D-II与甲状腺激素浓度之间存在反比关系。对于甲状腺切除和对照母亲的胎儿,这些相关性并不相同。在来自甲状腺切除大坝的胎儿中,与对照大坝的后代相比,大脑5'D-II对大脑T4的降低更敏感。目前的结果描述了大鼠大脑5'D-II活性的发展变化及其受甲状腺激素的调节。尽管胎儿血浆T3占成人水平的10%,但胎儿脑中T3的浓度几乎增加到成人水平,这表明从T4产生局部T3并因此在胎儿脑中产生5'D-II的重要作用。此外,大脑5'D-II对甲状腺激素缺乏症有反应,当胎儿为甲状腺功能减退时,母体甲状腺激素可改变大脑5'D-II。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号